Diagnostic efficacy of serological and epigenetic methods of screening diagnostics of colorectal cancer

Aim of investigation. Development of adequate screening and diagnostic algorithms on colorectal cancer detection.Material and methods. The main group included 204 patients with colorectal cancer (CRC),that has been revealed at screening of 1669 patients by immunochemical fecal occult blood test (FOB...

Full description

Saved in:
Bibliographic Details
Main Authors: O. I. Kit, D. V. Burtsev, A. Yu. Maksimov
Format: Article
Language:Russian
Published: Gastro LLC 2014-12-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/1156
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860032771457024
author O. I. Kit
D. V. Burtsev
A. Yu. Maksimov
author_facet O. I. Kit
D. V. Burtsev
A. Yu. Maksimov
author_sort O. I. Kit
collection DOAJ
description Aim of investigation. Development of adequate screening and diagnostic algorithms on colorectal cancer detection.Material and methods. The main group included 204 patients with colorectal cancer (CRC),that has been revealed at screening of 1669 patients by immunochemical fecal occult blood test (FOBT). Control group included 213 CRC patients who have addressed oncologic institutions for intestinal or general complaints independently. Screening program included: immunochromatographic FOBT, blood test for tumor markers — carcinoembryonic antigen (CEA), oncoantigens СА 19-9, СА 242), methylated DNA of septin 9 gene.Results. Diagnostic efficacy of CRC screening diagnostics by testing of blood levels of CEA, СА 242 and СА 19-9 was 40,4, 50,8 and 51,7% respectively. Epigenetic tests for DNA methylate of SEPT9 gene in blood as screening procedure was characterized by high diagnostic efficacy — 86,5%. At the initial stage of screening diagnostics optimum combination of methods is immunochemical FOBT at 100 ng/ml threshold and assessment of DNA methylate of gene SEPT9 in blood. Diagnostic efficacy of the 1-st stage of screening diagnostics was 90%.Conclusions. The initial stage of screening diagnostics CRC including immunochemical FOBT tests at threshold of 100 ng/ml, assessment of DNA methylate of SEPT9 gene in blood, provide optimum ratio of sensitivity and specificity and cost efficacy.
format Article
id doaj-art-2345cd39ecb9444e9382b27d820a90aa
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2014-12-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-2345cd39ecb9444e9382b27d820a90aa2025-02-10T16:14:39ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732014-12-012465158751Diagnostic efficacy of serological and epigenetic methods of screening diagnostics of colorectal cancerO. I. Kit0D. V. Burtsev1A. Yu. Maksimov2Federal state-funded institution «Rostov Research Oncology Institute» Ministry of healthcare of Russian FederationFederal state-funded institution of the Rostov area «Regional diagnostic center»Federal state-funded institution «Rostov Research Oncology Institute» Ministry of healthcare of Russian FederationAim of investigation. Development of adequate screening and diagnostic algorithms on colorectal cancer detection.Material and methods. The main group included 204 patients with colorectal cancer (CRC),that has been revealed at screening of 1669 patients by immunochemical fecal occult blood test (FOBT). Control group included 213 CRC patients who have addressed oncologic institutions for intestinal or general complaints independently. Screening program included: immunochromatographic FOBT, blood test for tumor markers — carcinoembryonic antigen (CEA), oncoantigens СА 19-9, СА 242), methylated DNA of septin 9 gene.Results. Diagnostic efficacy of CRC screening diagnostics by testing of blood levels of CEA, СА 242 and СА 19-9 was 40,4, 50,8 and 51,7% respectively. Epigenetic tests for DNA methylate of SEPT9 gene in blood as screening procedure was characterized by high diagnostic efficacy — 86,5%. At the initial stage of screening diagnostics optimum combination of methods is immunochemical FOBT at 100 ng/ml threshold and assessment of DNA methylate of gene SEPT9 in blood. Diagnostic efficacy of the 1-st stage of screening diagnostics was 90%.Conclusions. The initial stage of screening diagnostics CRC including immunochemical FOBT tests at threshold of 100 ng/ml, assessment of DNA methylate of SEPT9 gene in blood, provide optimum ratio of sensitivity and specificity and cost efficacy.https://www.gastro-j.ru/jour/article/view/1156colorectal cancerscreening diagnosticstumor markersdiagnostics
spellingShingle O. I. Kit
D. V. Burtsev
A. Yu. Maksimov
Diagnostic efficacy of serological and epigenetic methods of screening diagnostics of colorectal cancer
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
colorectal cancer
screening diagnostics
tumor markers
diagnostics
title Diagnostic efficacy of serological and epigenetic methods of screening diagnostics of colorectal cancer
title_full Diagnostic efficacy of serological and epigenetic methods of screening diagnostics of colorectal cancer
title_fullStr Diagnostic efficacy of serological and epigenetic methods of screening diagnostics of colorectal cancer
title_full_unstemmed Diagnostic efficacy of serological and epigenetic methods of screening diagnostics of colorectal cancer
title_short Diagnostic efficacy of serological and epigenetic methods of screening diagnostics of colorectal cancer
title_sort diagnostic efficacy of serological and epigenetic methods of screening diagnostics of colorectal cancer
topic colorectal cancer
screening diagnostics
tumor markers
diagnostics
url https://www.gastro-j.ru/jour/article/view/1156
work_keys_str_mv AT oikit diagnosticefficacyofserologicalandepigeneticmethodsofscreeningdiagnosticsofcolorectalcancer
AT dvburtsev diagnosticefficacyofserologicalandepigeneticmethodsofscreeningdiagnosticsofcolorectalcancer
AT ayumaksimov diagnosticefficacyofserologicalandepigeneticmethodsofscreeningdiagnosticsofcolorectalcancer